IOTOD 2013

IOTOD 2013’s programme focused on optimising the quality of care, safety issues in opioid dependence and managing complex patients.

The programme covered emerging issues such as minimising the risks associated with medication transfers, recognising drug–drug interactions, treating co-existing HCV, as well as practical approaches to drug addiction and pregnancy.

Chairs

Professor Sharon Walsh

Professor of Behavioral Science and Psychiatry Center on Drug and Alcohol Research, University of Kentucky

Lexington, KY, USA

Scientific Committee

Marc Auriacombe

Professor of Psychiatry and Addiction Medicine, University of Bordeaux

Bordeaux, France

Maurice Dematteis

Head of the Department of Addictions, University Hospital of Grenoble

Grenoble, France

John Marsden

Professor of Addiction Psychology, Addictions Department, King’s College London

London, UK

Nicholas Lintzeris

Drug and Alcohol Services, South-East Sydney Local Health District

Sydney, Australia

Speakers

Professor Elinore McCance-Katz

Professor of Psychiatry, University of California San Francisco

USA

Professor John Strang

Director, National Addiction Centre, King's College London

London, UK

Marc Auriacombe

Professor of Psychiatry and Addiction Medicine, University of Bordeaux

Bordeaux, France

Professor Michael Soyka

Medical Director, Psychiatric Hospital Meiringen

Meiringen, Switzerland

Dr Daniel Fuster

Internist, Addiction Unit, Universitari Germans Trias i Pujol

Badalona, Spain

Professor Seddon Savage

Director, Dartmouth Center on Addiction Recovery and Education

New Hampshire, USA

Dr Jenny Bearn

Consultant Psychiatrist/Honorary Senior Lecturer, South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, King’s College London

London, UK

Dr Laurent Gourarier

Psychiatrist and Additcion Specialist, La Terrasse, Hôpital Maison Blanche

Paris, France

Professor Mark Haigney

Professor of Medicine and Pharmacology and Director of Cardiology, F Edward Hébert School of Medicine

Bethesda, MD, USA

Professor David Fiellin

Professor of Medicine, Investigative Medicine and Public Health, Yale University School of Medicine

USA

Webcasts

Manoeuvres in the fog: drug-drug interactions in OST
Practicalities of transitioning between opioid agonist treatments
New horizons for treatment: translating the latest research into clinical practice
Tailoring behavioural interventions: emerging evidence and practical implications
View all webcasts